TC
LGND icon

TownSquare Capital’s Ligand Pharmaceuticals LGND Stock Holding History

TownSquare Capital’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,259
Closed -$484K – 509
2025
Q2 		$484K Sell
4,259
-32,515
-88% -$3.48M 0.05% 349
2025
Q1 		$3.87M Buy
36,774
+2,235
+6% +$253K 0.04% 385
2024
Q4 		$3.7M Buy
34,539
+4,726
+16% +$534K 0.04% 390
2024
Q3 		$2.98M Buy
29,813
+3,140
+12% +$316K 0.04% 431
2024
Q2 		$2.25M Buy
+26,673
New +$2.12M 0.03% 478
2022
Q2 		– Sell
-6,891
Closed -$484K – 752
2022
Q1 		$484K Buy
6,891
+1,109
+19% +$80.5K 0.01% 501
2021
Q4 		$557K Buy
5,782
+3,193
+123% +$295K 0.01% 460
2021
Q3 		$225K Buy
+2,589
New +$200K 0.01% 643

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital's LGND Position: Q3 2025 in Review

TownSquare Capital sold out of Ligand Pharmaceuticals (LGND) in Q3 2025, closing a stake of 4,259 shares — an estimated $484K sold.

TownSquare Capital first reported a position in LGND in Q3 2021 and held it in 8 quarters. The position peaked at $3.87M in Q1 2025. 314 funds tracked by Wall St. Rank hold LGND as of Q3 2025.

  • TownSquare Capital reported no remaining Ligand Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • TownSquare Capital sold 4,259 Ligand Pharmaceuticals shares in Q3 2025, an estimated $484K.
  • TownSquare Capital first reported a position in Ligand Pharmaceuticals in Q3 2021 and held it in 8 quarters.
  • TownSquare Capital's Ligand Pharmaceuticals position peaked at $3.87M in Q1 2025.
  • 314 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2025.

Based on TownSquare Capital's 13F filing for Q3 2025, filed 3 Nov 2025.